Hazardous drinking and alcohol use disordersShow others and affiliations
2022 (English)In: NATURE REVIEWS DISEASE PRIMERS, ISSN 2056-676X, Vol. 8, no 1, article id 80Article in journal (Refereed) Published
Abstract [en]
Alcohol is one of the most widely consumed psychoactive drugs globally. Hazardous drinking, defined by quantity and frequency of consumption, is associated with acute and chronic morbidity. Alcohol use disorders (AUDs) are psychiatric syndromes characterized by impaired control over drinking and other symptoms. Contemporary aetiological perspectives on AUDs apply a biopsychosocial framework that emphasizes the interplay of genetics, neurobiology, psychology, and an individuals social and societal context. There is strong evidence that AUDs are genetically influenced, but with a complex polygenic architecture. Likewise, there is robust evidence for environmental influences, such as adverse childhood exposures and maladaptive developmental trajectories. Well-established biological and psychological determinants of AUDs include neuroadaptive changes following persistent use, differences in brain structure and function, and motivational determinants including overvaluation of alcohol reinforcement, acute effects of environmental triggers and stress, elevations in multiple facets of impulsivity, and lack of alternative reinforcers. Social factors include bidirectional roles of social networks and sociocultural influences, such as public health control strategies and social determinants of health. An array of evidence-based approaches for reducing alcohol harms are available, including screening, pharmacotherapies, psychological interventions and policy strategies, but are substantially underused. Priorities for the field include translating advances in basic biobehavioural research into novel clinical applications and, in turn, promoting widespread implementation of evidence-based clinical approaches in practice and health-care systems.
Place, publisher, year, edition, pages
NATURE PORTFOLIO , 2022. Vol. 8, no 1, article id 80
National Category
Substance Abuse
Identifiers
URN: urn:nbn:se:liu:diva-191756DOI: 10.1038/s41572-022-00406-1ISI: 000918330100002PubMedID: 36550121OAI: oai:DiVA.org:liu-191756DiVA, id: diva2:1736496
Note
Funding Agencies|Peter Boris Chair in Addictions Research; Tier 1 Canada Research Chair in Translational Addiction Research; Canadian Institutes of Health Research, Health Canada; National Institutes of Health (NIH) [R01AA024930, R01AA025911, R21 AA027679, R01AA025849]; NIH [R01AA025849, K24AA026876, K24AA022136, P50DA037844, R01AA02628, R01AA029688, K24AA025704]; Swedish Research Council [2013-07434, 2019-01138]; Knut and Alice Wallenberg Foundation; National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism
2023-02-132023-02-132023-02-13